- Healthcare
- Social
- Retail
- Main
You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current
Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2009
Senomyx, Inc.
(Exact name of registrant as
specified in its charter)
|
Delaware |
|
000-50791 |
|
33-0843840 |
|
4767 Nexus Centre Drive |
|
92121 |
Registrants telephone number, including area code: (858) 646-8300
Not
Applicable.
(Former name or
former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
|
Departure of Directors or Principal Officers; Election of
Directors; Appointment of Certain |
(e)
2009 Named Executive Officer Base Salary and Stock Option Grants
On February 5, 2009, the Compensation Committee of our Board of Directors approved increases in base salary and the grant of additional stock options for our executive officers. The total number of stock options granted to each individual was determined based on the individuals 2008 performance and also reflects a decision by the Compensation Committee to provide additional long-term retention incentive for the continuation of service of our executive officers. The following table sets forth 2009 base salaries and the number of shares underlying the stock option grants:
|
Name |
|
2009 Base Salary |
|
Stock Options |
|
|
|
Kent Snyder |
|
$ |
480,000 |
|
349,900 |
|
|
Mark J. Zoller, Ph.D. |
|
$ |
334,000 |
|
174,000 |
|
|
John Poyhonen |
|
$ |
318,000 |
|
156,300 |
|
|
Sharon Wicker |
|
$ |
308,000 |
|
146,700 |
|
|
David Berger |
|
$ |
287,000 |
|
148,900 |
|
The stock options described above (i) were granted effective as of February 16, 2009 pursuant to our 2004 Equity Incentive Plan, (ii) terminate ten years after February 16, 2009 or earlier in the event the optionholders service to us is terminated and (iii) have an exercise price per share equal to the closing price of our common stock as reported on the Nasdaq Stock Market on February 13, 2009. Subject to the optionholders continued service to us, 25% of the shares of common stock subject to such stock options vest on the first anniversary of the date of grant, and the remaining shares vest monthly over the following three years; subject to suspension of vesting during periods of certain extended leaves.
Incentive Cash Bonuses
Our Board of Directors annually establishes corporate goals for the ensuing fiscal year. The Compensation Committee also establishes individual goals each year for the executive officers. In connection with these goals, the Compensation Committee establishes a maximum incentive cash bonus amount for each executive officer in the event that all corporate and, in the case of each executive officer other than our Chief Executive Officer, individual goals are achieved. Our Chief Executive Officers incentive cash bonus is based entirely upon the achievement of corporate goals. Incentive cash bonuses for each other executive officer are based 80% on the achievement of corporate goals and 20% on the achievement of individual goals. Actual incentive cash bonuses paid are solely at the discretion of the Compensation Committee and are based upon the Compensation Committees determination of corporate and, as applicable, individual goals actually achieved. Based on that determination, on February 5, 2009, the Compensation Committee approved 2008 incentive cash bonuses to each executive officer. Our policy is that an employee must be actively employed to receive payout of an incentive cash bonus. For 2008, the incentive cash bonuses approved for each executive officer were as follows:
|
Name |
|
2008 Bonus |
|
|
|
Kent Snyder |
|
$ |
195,408 |
|
|
Mark J. Zoller, Ph.D. |
|
$ |
90,675 |
|
|
John Poyhonen |
|
$ |
89,304 |
|
|
Sharon Wicker |
|
$ |
87,540 |
|
|
David Berger |
|
$ |
63,989 |
|
2009 Executive Bonus Plan
On February 5, 2009, the Compensation Committee approved our 2009 Executive Bonus Plan, a summary of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
Item 8.01 |
|
Other Events. |
On February 5, 2009, based upon the recommendation of our Compensation Committee, our Board of Directors approved a special stock option award of 11,300 stock options for each of our non-employee directors. The stock option awards are intended to supplement the annual stock option awards contemplated by our non-employee director compensation policy. The purpose of the special stock option grant is to provide additional long-term retention incentive for the continuation of service of our non-employee directors. Accordingly, subject to the optionholders continued service to us, the share vest monthly over a three year vesting period.
The stock options for non-employee directors described above (i) were granted effective as of February 16, 2009 pursuant to our 2004 Equity Incentive Plan, (ii) terminate ten years after February 16, 2009 or earlier in the event the optionholders service to us is terminated and (iii) have an exercise price per share equal to the closing price of our common stock as reported on the Nasdaq Stock Market on February 13, 2009.
|
Item 9.01. |
|
Financial Statements and Exhibits. |
|
(d) |
|
Exhibits |
|
|
|
|
|
99.1 |
|
Summary Description of Senomyx, Inc. 2009 Executive Bonus Plan. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
SENOMYX, INC. |
|
|
|
|
|
|
|
|
|
By: |
/S/ DAVID BERGER |
|
|
|
|
David Berger |
|
|
|
|
Vice President, General Counsel and Corporate Secretary |
|
|
|
|
|
|
Date: February 9, 2009 |
|
|
|
3